Stockscreener 앱 받기
1.51
6.21%
-0.10
시간 외 거래:
1.51
전일 마감가:
$1.61
열려 있는:
$1.63
하루 거래량:
279.51K
Relative Volume:
0.79
시가총액:
$72.63M
수익:
-
순이익/손실:
$-56.85M
주가수익비율:
-0.9686
EPS:
-1.559
순현금흐름:
-
1주 성능:
-17.93%
1개월 성능:
-25.25%
6개월 성능:
-22.16%
1년 성능:
-85.59%
1일 변동 폭
$1.51
$1.64
1주일 범위
$1.51
$1.82
52주 변동 폭
$1.51
$10.69
Fractyl Health Inc Stock (GUTS) Company Profile
명칭
Fractyl Health Inc
전화
781-902-8800
주소
3 VAN DE GRAAFF DRIVE, BURLINGTON
GUTS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GUTS
Fractyl Health Inc
|
1.51 | 72.63M | 0 | -56.85M | 0 | -1.559 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.32 | 120.86B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
710.00 | 77.62B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
646.64 | 39.62B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
276.19 | 35.50B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.61 | 28.20B | 3.30B | -501.07M | 1.03B | -2.1146 |
Fractyl Health Inc Stock (GUTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-02-28 | 개시 | Evercore ISI | Outperform |
| 2024-02-27 | 개시 | BofA Securities | Buy |
| 2024-02-27 | 개시 | Morgan Stanley | Overweight |
Fractyl Health Inc 주식(GUTS)의 최신 뉴스
Fractyl Health (NASDAQ:GUTS) Price Target Cut to $10.00 by Analysts at Morgan Stanley - MarketBeat
Fractyl Health, Inc. (NASDAQ:GUTS) CEO Harith Rajagopalan Sells 90,972 Shares - MarketBeat
Potential Price Increase for Fractyl Health Inc (GUTS) After Recent Insider Activity - Knox Daily
BlackRock, Inc. Increases Stake in Fractyl Health Inc: A Strategic Move in Biotechnology - GuruFocus.com
Fractyl Health, Inc. (NASDAQ:GUTS) Stock Position Lifted by JPMorgan Chase & Co. - Defense World
Fractyl Health, Inc. (NASDAQ:GUTS) Insider Jay David Caplan Sells 22,346 Shares - MarketBeat
Fractyl Health Inc (GUTS) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle
Trading Day Triumph: Fractyl Health Inc (GUTS) Ends at 1.70, a -7.61 Surge/Plunge - The Dwinnex
Fractyl Health (NASDAQ:GUTS) Given New $10.00 Price Target at Morgan Stanley - Defense World
Fractyl Health announces layoffs as it pivots to gene therapy - Mass Device
Burlington biotech company announces layoffs, pivots research focus - NBC Boston
Fractyl Health Announces Increased Focus on Groundbreaking - GlobeNewswire
Fractyl Health pivots Type 2 diabetes device therapy toward obesity and GLP-1s, lays off 17% of staff - Fierce Biotech
Fractyl Health announces increased focus on Revita, Rejuva programs - TipRanks
Fractyl Health Reprioritizes Focus on REMAIN-1 Study - TipRanks
Weight Loss Breakthrough: Fractyl's Post-GLP-1 Maintenance Program Shows Promise as Company Pivots Strategy - StockTitan
Burlington biotech slims down 17% of workforce, focuses on weight maintenance treatment - The Business Journals
Barclays PLC Grows Position in Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Fractyl Health, Inc. (NASDAQ:GUTS) Sees Large Growth in Short Interest - MarketBeat
Head-To-Head Analysis: Tactile Systems Technology (NASDAQ:TCMD) and Fractyl Health (NASDAQ:GUTS) - Defense World
Fractyl Health’s Promising Progress in Weight Management - TipRanks
Fractyl Health Announces Positive Initial Clinical Results Demonstrating Weight Maintenance Following GLP-1 Discontinuation and Revita Procedure in First Patient of the REVEAL-1 Cohort - The Manila Times
Fractyl Health Announces Positive Initial Clinical Results - GlobeNewswire
Fractyl Health Reports Breakthrough: Patient Maintains 15% Weight Loss After GLP-1 Discontinuation - StockTitan
Geode Capital Management LLC Has $1.27 Million Stock Position in Fractyl Health, Inc. (NASDAQ:GUTS) - MarketBeat
Geode Capital Management LLC Acquires 313,335 Shares of Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Barclays PLC Has $121,000 Position in Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Here’s Why Fractyl Health, Inc. (NASDAQ:GUTS) Is Among the Best Diabetes Stocks to Buy Under $10 - Insider Monkey
State Street Corp Purchases 63,968 Shares of Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
HighTower Advisors LLC Takes $38,000 Position in Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
BNP Paribas Financial Markets Increases Stake in Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Charles Schwab Investment Management Inc. Has $204,000 Stock Position in Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Critical Contrast: Fractyl Health (GUTS) and Its Rivals - Defense World
GUTSFractyl Health, Inc. Latest Stock News & Market Updates - StockTitan
Fractyl Health Unveils Promising Preclinical Data Demonstrating Safety and Feasibility of Local Delivery of RJVA-001 Rejuva® Smart GLP-1™ Pancreatic Gene Therapy at the World Congress Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRD - GlobeNewswire
Fractyl Health Unveils Promising Preclinical Data Demonstrating Safety and Feasibility of Local - The Bakersfield Californian
Fractyl Health's GLP-1 Gene Therapy Shows Breakthrough Results in Preclinical Study5x Higher Expression - StockTitan
Fractyl Health to Present New Preclinical Data from its Rejuva® Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the World Congress Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC) - The Manila Times
Fractyl Health to Present Breakthrough GLP-1 Gene Therapy Data for Diabetes Treatment at WCIRDC 2024 - StockTitan
Is Fractyl Health (NASDAQ:GUTS) Using Debt Sensibly? - Simply Wall St
Analysts Update Their Estimates For Alpha Teknova Inc - Stocks Register
Pulmonx (NASDAQ:LUNG) vs. Fractyl Health (NASDAQ:GUTS) Head-To-Head Review - Defense World
Fractyl Health to Participate in the Upcoming December Conferences - GlobeNewswire
Fractyl Health CEO to Present at Evercore, Piper Sandler Healthcare Conferences - StockTitan
Fractyl Health Stock Price Prediction: 2024, 2025, 2030 - Benzinga
Why This Penny Stock Lost 13% Last Week While Markets Soared - MSN
Comparing Fractyl Health (GUTS) and Its Rivals - Defense World
Comparing Fractyl Health (GUTS) and Its Peers - Defense World
Head to Head Analysis: Fractyl Health (GUTS) versus Its Peers - Defense World
Fractyl Health management to meet virtually with B. Riley - Nasdaq
Lee Ainslie's Strategic Reduction in Fractyl Health Inc Holdings - GuruFocus.com
Fractyl Health Inc (GUTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Fractyl Health Inc 주식 (GUTS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Rajagopalan Harith | Chief Executive Officer |
Jan 30 '25 |
Option Exercise |
1.70 |
20,948 |
35,612 |
512,277 |
| Rajagopalan Harith | Chief Executive Officer |
Jan 31 '25 |
Sale |
1.82 |
90,972 |
165,205 |
491,329 |
| Rajagopalan Harith | Chief Executive Officer |
Jan 30 '25 |
Sale |
1.95 |
20,948 |
40,798 |
491,329 |
| Caplan Jay David | President, Chief Product Off. |
Jan 31 '25 |
Option Exercise |
1.70 |
22,346 |
37,988 |
175,890 |
| Caplan Jay David | President, Chief Product Off. |
Jan 30 '25 |
Option Exercise |
1.70 |
21,472 |
36,502 |
175,016 |
| Caplan Jay David | President, Chief Product Off. |
Jan 30 '25 |
Sale |
1.95 |
21,472 |
41,802 |
153,544 |
| Caplan Jay David | President, Chief Product Off. |
Jan 31 '25 |
Sale |
1.81 |
22,346 |
40,464 |
153,544 |
1.03%
자본화:
|
볼륨(24시간):